Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. It is not yet known which regimen of chemotherapy is more
effective for chronic lymphocytic leukemia.
PURPOSE: This randomized phase III trial is studying chlorambucil to see how well it works
compared to fludarabine and cyclophosphamide or fludarabine alone in treating patients with
newly diagnosed chronic lymphocytic leukemia.